Opt-e-scrip is Personalized Medicine

Opt-e-scrip is the first and only Pharmacy Benefit Manager to offer Personalized Medicine Formularies.

Our Mission is to provide employer groups with a unique Formulary using Personalized Medicine Tests (PMT's) which compare an expensive chronic care drug to a therapeutically similar, but inexpensive, off-patent drug. The Formulary's first benefit is that the patient's drug outcomes are optimized. The second, equally important benefit, is that utilization rates for inexpensive drugs increase based on the patient's own clinical response, resulting in a medically-justified savings to the employer. The second benefit arises from the fact that the FDA does not require that new drugs be proven superior to existing drugs in either efficacy or safety. Therefore, an established, inexpensive drug that was yesterday's high-priced, brand-name product often is equal or superior to today's more expensive drug in a given patient.

The Problem with other Formularies offered by insurance companies and conventional pharmacy benefit managers (PBMs) is that they can interfere with the physician/patient relationship by encouraging utilization of generics and name brand drugs based on financial rather than clinical considerations. For example, since generics generally come with lower co-pays than name brand drugs, the physician may be reluctant to prescribe a name brand drug even though it may provide better outcomes for the patient. Conversely, PBMs and insurance companies often receive financial incentives from pharmaceutical companies to offer certain name brand drugs at lower co-pays than other name brand drugs. This can deter the physician from prescribing a higher-copay brand name drug even though it might be better for the patient.

The Solution is the Opt-e-scrip Formulary, which allows physicians to measure chronic care drug effectiveness and safety in the individual patient using our patented technology to compare any name brand drug the physician chooses to a less expensive, therapeutically similar drug. The personalized medicine test (PMT) always comes with the lowest co-pay in the drug benefit plan, so financial considerations do not influence the choice of drugs prescribed.

Nevertheless, despite making all name brand and generic drugs available at the same low co-pay, PMTs objectively identify the more cost-effective drug for each patient. This results in significant savings to employers and more satisfied employees.

Someday all Formularies will help physicians prescribe chronic care drugs this way.™

 

If you are a patient using an Opt-e-scrip personalized medicine test kit, please enter your Diary Responses using our online Patient Diary Interface.

 

As a prognostics company, we do not perform medical services. Here's why.